<DOC>
	<DOCNO>NCT00862459</DOCNO>
	<brief_summary>The purpose study look safety ( side effect ) efficacy ( well work ) Gadavist use take image brain spine . The result MRI Gadavist Injection compare result MR image take without contrast result MR image take OptiMARK .</brief_summary>
	<brief_title>Dose Finding Study Gadavist Central Nervous System ( CNS ) Magnetic Resonance Imaging ( MRI )</brief_title>
	<detailed_description>Safety issue address Adverse Events section</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Spinal Cord Diseases</mesh_term>
	<criteria>Patients either know highly suspected focal area disruption blood brain barrier ( BBB ) ( eg , primary secondary tumor , focal inflammatory demyelinate disorder ) and/or abnormal vascularity CNS , schedule undergo routine contrastenhanced MRI CNS . Patients untreated brain tumor constitute minimum 50 % study population patient treat brain tumor limit maximum 20 % study population Is female patient pregnant nursing . Is female childbearing potential negative urine pregnancy test day administration gadobutrol comparator treatment . Has receive investigational product within 30 day prior enrol study . Has previously enrol study study use gadobutrol . Has contraindication MRI examination . Has history severe allergic anaphylactoid reaction allergen include drug contrast agent . Has receive contrast agent within 24 hour prior gadobutrol contrast administration , schedule receive contrast agent within 72 hour gadobutrol study . Is consider clinically unstable his/her clinical course study period unpredictable ( eg , due previous surgery , acute renal failure ) . Has treat high dose ( &gt; 55 cobalt Gy equivalent ) photon radiation global radiotherapy CNS lesion time enter study . Is schedule receive chemotherapy radiotherapy study period . Is expect scheduled change treatment procedure comparator gadobutrol MRIs may alter interpretation . Is schedule likely require biopsy surgery within 72 hour gadobutrol MRI procedure , schedule undergone intervention comparator gadobutrol study . Has severe cardiovascular disease . Has contraindication OptiMARK accord package insert . Has 30 brain lesion detect prior image examination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Contrast Agents</keyword>
</DOC>